Related Experiment Video
Updated: Apr 25, 2026
06:59
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
720
[Present status of interventional pulmonology]
Keishi Ohtani1, Norihiko Ikeda
1Department of Surgery 1, Tokyo Medical University, Tokyo, Japan.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|August 21, 2014
Summary
Endobronchial interventions relieve airway obstruction symptoms like dyspnea and hemoptysis. Treatment selection is crucial for managing malignant and benign airway tumors effectively.
Area of Science:
- Pulmonology and Interventional Bronchology
- Oncology
- Medical Technology
Context:
- Malignant and benign central airway obstruction significantly impacts patient quality of life, causing dyspnea and hemoptysis.
- Bronchoscopic intervention offers immediate symptom relief for airway obstruction.
- Established endobronchial therapies include laser ablation, coagulation, and stent placement.
Purpose:
- To review established endobronchial therapies for malignant and benign airway obstruction.
- To discuss the advantages and disadvantages of various bronchoscopic interventions.
- To emphasize the importance of selecting appropriate treatment methods for optimal patient outcomes.
Summary:
- Neodymium Yttrium Aluminum Garnet (Nd:YAG) laser therapy provides thermal ablation but carries a risk of perforation.
- Photodynamic therapy shows curative potential for early lung cancer and is approved for advanced stages.
- Stent placement effectively re-establishes airway patency but is associated with restenosis, migration, and mucus plugs.
Impact:
- Provides a comparative overview of endobronchial treatment modalities for airway obstruction.
- Highlights the critical role of personalized treatment selection in managing airway tumors.
- Informs clinical decision-making for interventional pulmonologists and oncologists.
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
746
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
746
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
608
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
608
01:27Peripheral Artery Disease III: Interprofessional Care
652
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
652
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
809
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
809
01:29Pulmonary Embolism I: Introduction
1.5K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
01:19Pulmonary Embolism I: Introduction
32
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
32